Piermont Capital Management Inc. - DEPOMED INC ownership

DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 167 filers reported holding DEPOMED INC in Q3 2017. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of DEPOMED INC
ValueSharesWeighting
Q3 2017$95,000
-74.0%
16,410
-51.6%
0.03%
-70.2%
Q2 2017$365,000
-27.3%
33,940
-15.2%
0.10%
-13.3%
Q1 2017$502,000
-30.4%
40,0000.0%0.12%
-27.3%
Q4 2016$721,000
+72.1%
40,000
+79.8%
0.16%
+20.4%
Q3 2015$419,000
-12.2%
22,2500.0%0.14%
-4.9%
Q2 2015$477,000
-4.4%
22,2500.0%0.14%
-5.3%
Q1 2015$499,00022,2500.15%
Other shareholders
DEPOMED INC shareholders Q3 2017
NameSharesValueWeighting ↓
DELTEC ASSET MANAGEMENT LLC 2,159,164$32,798,0007.35%
Senvest Management, LLC 4,515,935$68,597,0006.42%
Broadfin Capital, LLC 2,313,702$35,145,0003.68%
HAYS ADVISORY LLC 512,820$7,790,0001.03%
Ghost Tree Capital, LLC 120,000$1,823,0000.99%
EMERALD MUTUAL FUND ADVISERS TRUST 647,096$9,829,0000.94%
TURNER INVESTMENTS LLC 817,177$12,413,0000.74%
EMERALD ADVISERS, LLC 681,346$10,350,0000.62%
TSP Capital Management Group, LLC 86,300$1,311,0000.60%
PERKINS CAPITAL MANAGEMENT INC 38,500$585,0000.49%
View complete list of DEPOMED INC shareholders